Latest Breaking News On - Sylvester comprehensive cancer center - Page 6 : comparemela.com

Research shows new treatment may enable more patients with high-risk blood cancers to receive stem cell transplants

Research shows new treatment may enable more patients with high-risk blood cancers to receive stem cell transplants
medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.

United statesMonzr al malkiAntonio jimenezNational marrow donor programCity of hope medical centerAmerican society of clinical oncologyEuropean hematology associationSylvester comprehensive cancer centerMemorial sloan kettering cancer centerUniversity of miami miller school medicineMiami miller schoolAmerican societyClinical oncologyNational marrow donorHope medical center

Sylvester Study: New Therapy May Boost Stem Cell Transplants in High-risk Cancer Patients

Sylvester Study: New Therapy May Boost Stem Cell Transplants in High-risk Cancer Patients
miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.

United statesAntonio jimenezMonzr al malkiCity of hope medical centerSylvester comprehensive cancer centerMemorial sloan kettering cancer centerEuropean hematology associationAmerican society of clinical oncologyUniversity of miami miller school medicineNational marrow donor programMiami miller schoolAmerican societyClinical oncologyNational marrow donorHope medical center

Sylvester Research Shows New Treatment May Enable

Sylvester Research Shows New Treatment May Enable
newswise.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from newswise.com Daily Mail and Mail on Sunday newspapers.

United statesAntonio jimenezMonzr al malkiSylvester comprehensive cancer centerNational marrow donor programUniversity of miami miller school medicineAmerican society of clinical oncologyMemorial sloan kettering cancer centerCity of hope medical centerEuropean hematology associationMiami miller schoolAmerican societyClinical oncologyNational marrow donorHope medical center

Recent FDA Committee Vote Could Speed Multiple Mye

An FDA committee voted unanimously last month to approve a new clinical endpoint, minimal residual disease, when evaluating proposed drugs to treat multipl

United statesMaryalice stelter stevensonGerald martiC ola landgrenSeanm devlinNational cancer instituteNational heartNational institutes of healthDrug administrationBlood instituteMemorial sloan kettering cancer centerUniversity of miami miller school medicineMyeloma research instituteSylvester comprehensive cancer centerMiami miller schoolNational institutes

Recent FDA committee vote could speed multiple myeloma drug approval

A U.S. Food and Drug Administration committee voted unanimously in April to approve a new clinical endpoint, minimal residual disease (MRD), when evaluating proposed drugs to treat multiple myeloma.

United statesC ola landgrenOla landgrenNational institutes of healthUniversity of miami miller school medicineDrug administrationNational cancer instituteMyeloma research instituteSylvester comprehensive cancer centerMiami miller schoolNational institutesBlood journal